All In Biotech

Free tool

FAERS Monitor: Lantus Solostar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 021081 or its brand name (Lantus Solostar, Insulin Glargine Recombinant). Reports on generic versions are filed under their own applications.

Reports

202,872

Serious

112,860

56% of reports

Hospitalization

58,331

Death reported

12,531

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased29,554
  • off label use13,004
  • nausea8,711
  • drug ineffective8,451
  • inappropriate schedule of product administration8,366
  • blood glucose decreased8,334
  • hypoglycaemia7,179
  • product storage error6,908
  • visual impairment6,568
  • diarrhoea6,177
  • fatigue6,032
  • dyspnoea5,652
  • malaise5,651
  • weight decreased5,645
  • vomiting5,587

Reports by year received

View as table
YearReports
20041,035
20051,804
20063,270
20073,327
20082,949
20093,916
20105,398
20116,269
20125,590
20138,148
201412,103
201518,871
201612,475
201711,285
201816,789
201913,842
202011,767
202110,694
20229,994
20238,875
202410,646
202513,310
202610,512

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,851,287 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood glucose decreasedSignal8,33421.621.1135,342
blood glucose increasedSignal29,55419.118.9431,302
hypoglycaemiaSignal7,17917.817.497,420
product storage errorSignal6,9088.88.644,144
visual impairmentSignal6,5685.75.624,526
inappropriate schedule of product administrationSignal8,3665.04.925,732
weight decreasedSignal5,6452.12.13,311
off label use13,0041.51.52,591
malaise5,6511.31.3492
vomiting5,5871.21.2252
nausea8,7111.11.1159
dyspnoea5,6521.01.07
diarrhoea6,1771.01.00
fatigue6,0320.80.8305
drug ineffective8,4510.70.61,538

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.